New PET scan could match breast cancer patients to the right drug
NCT ID NCT06830382
First seen Nov 20, 2025 · Last updated May 09, 2026 · Updated 22 times
Summary
This study is testing a new type of PET scan that looks for a protein called HER2 on breast cancer cells. The goal is to see if this scan can better predict which patients with advanced breast cancer will benefit from a targeted drug called T-DXd. About 70 women with metastatic breast cancer will receive the scan and then treatment, and researchers will compare scan results to how well the cancer responds. If successful, this approach could help doctors choose the most effective therapy for each patient while avoiding unnecessary side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karolinska University hospital
RECRUITINGSolna, 17176, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.